These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

198 related articles for article (PubMed ID: 9661905)

  • 21. Cell cycle-related variation and tissue-restricted expression of human cyclin D1 protein.
    Bartkova J; Lukas J; Strauss M; Bartek J
    J Pathol; 1994 Mar; 172(3):237-45. PubMed ID: 8195927
    [TBL] [Abstract][Full Text] [Related]  

  • 22. A comparison of cell cycle markers in well-differentiated lobular and ductal carcinomas.
    Soslow RA; Carlson DL; Horenstein MG; Osborne MP
    Breast Cancer Res Treat; 2000 May; 61(2):161-70. PubMed ID: 10942102
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Expression patterns of cyclins D1, E and cyclin-dependent kinase inhibitors p21waf1/cip1, p27kip1 in colorectal carcinoma: correlation with other cell cycle regulators (pRb, p53 and Ki-67 and PCNA) and clinicopathological features.
    Ioachim E
    Int J Clin Pract; 2008 Nov; 62(11):1736-43. PubMed ID: 19143860
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Expression patterns of cyclins D1, E in laryngeal epithelial lesions: correlation with other cell cycle regulators (p53, pRb, Ki-67 and PCNA) and clinicopathological features.
    Ioachim E; Peschos D; Goussia A; Mittari E; Charalabopoulos K; Michael M; Salmas M; Vougiouklakis T; Assimakopoulos D; Agnantis NJ
    J Exp Clin Cancer Res; 2004 Jun; 23(2):277-83. PubMed ID: 15354413
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Cyclin D1 and retinoblastoma gene expression in human breast carcinoma: correlation with tumour proliferation and oestrogen receptor status.
    Jares P; Rey MJ; Fernández PL; Campo E; Nadal A; Muñoz M; Mallofré C; Muntané J; Nayach I; Estapé J; Cardesa A
    J Pathol; 1997 Jun; 182(2):160-6. PubMed ID: 9274525
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Cyclin D1 gene expression in human cervical neoplasia.
    Nichols GE; Williams ME; Gaffey MJ; Stoler MH
    Mod Pathol; 1996 Apr; 9(4):418-25. PubMed ID: 8729983
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Molecular and immunochemical analyses of RB1 and cyclin D1 in human ductal pancreatic carcinomas and cell lines.
    Huang L; Lang D; Geradts J; Obara T; Klein-Szanto AJ; Lynch HT; Ruggeri BA
    Mol Carcinog; 1996 Feb; 15(2):85-95. PubMed ID: 8599583
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Identification of cyclin D1- and estrogen-regulated genes contributing to breast carcinogenesis and progression.
    Yang C; Trent S; Ionescu-Tiba V; Lan L; Shioda T; Sgroi D; Schmidt EV
    Cancer Res; 2006 Dec; 66(24):11649-58. PubMed ID: 17178859
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Should histologic type be taken into account when considering neoadjuvant chemotherapy in breast carcinoma?
    Sullivan PS; Apple SK
    Breast J; 2009; 15(2):146-54. PubMed ID: 19292800
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Automated image analysis of cyclin D1 protein expression in invasive lobular breast carcinoma provides independent prognostic information.
    Tobin NP; Lundgren KL; Conway C; Anagnostaki L; Costello S; Landberg G
    Hum Pathol; 2012 Nov; 43(11):2053-61. PubMed ID: 22647349
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Protein expression and molecular analysis of c-myc gene in primary breast carcinomas using immunohistochemistry and differential polymerase chain reaction.
    Naidu R; Wahab NA; Yadav M; Kutty MK
    Int J Mol Med; 2002 Feb; 9(2):189-96. PubMed ID: 11786932
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Cyclin D1 and p16INK4A expression predict reduced survival in carcinoma of the anterior tongue.
    Bova RJ; Quinn DI; Nankervis JS; Cole IE; Sheridan BF; Jensen MJ; Morgan GJ; Hughes CJ; Sutherland RL
    Clin Cancer Res; 1999 Oct; 5(10):2810-9. PubMed ID: 10537346
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Cyclin-dependent kinase inhibitor p27Kip1 expression and interaction with other cell cycle-associated proteins in mammary carcinoma.
    Gillett CE; Smith P; Peters G; Lu X; Barnes DM
    J Pathol; 1999 Jan; 187(2):200-6. PubMed ID: 10365095
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Loss of the expression of the tumor suppressor gene ARHI is associated with progression of breast cancer.
    Wang L; Hoque A; Luo RZ; Yuan J; Lu Z; Nishimoto A; Liu J; Sahin AA; Lippman SM; Bast RC; Yu Y
    Clin Cancer Res; 2003 Sep; 9(10 Pt 1):3660-6. PubMed ID: 14506155
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Clinical, histopathologic, and immunohistochemical features of microglandular adenosis and transition into in situ and invasive carcinoma.
    Khalifeh IM; Albarracin C; Diaz LK; Symmans FW; Edgerton ME; Hwang RF; Sneige N
    Am J Surg Pathol; 2008 Apr; 32(4):544-52. PubMed ID: 18300793
    [TBL] [Abstract][Full Text] [Related]  

  • 36. The role of HER2/neu overexpression/amplification in the progression of ductal carcinoma in situ to invasive carcinoma of the breast.
    Latta EK; Tjan S; Parkes RK; O'Malley FP
    Mod Pathol; 2002 Dec; 15(12):1318-25. PubMed ID: 12481013
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Cyclin D1 expression in invasive breast cancer. Correlations and prognostic value.
    van Diest PJ; Michalides RJ; Jannink L; van der Valk P; Peterse HL; de Jong JS; Meijer CJ; Baak JP
    Am J Pathol; 1997 Feb; 150(2):705-11. PubMed ID: 9033283
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Decreasing of p27(Kip1)and cyclin E protein levels is associated with progression from superficial into invasive bladder cancer.
    Kamai T; Takagi K; Asami H; Ito Y; Oshima H; Yoshida KI
    Br J Cancer; 2001 May; 84(9):1242-51. PubMed ID: 11336477
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Prognostic value of cell cycle regulator molecules in surgically resected stage I and II breast cancer.
    Peters MG; Vidal Mdel C; Giménez L; Mauro L; Armanasco E; Cresta C; Bal de Kier Joffé E; Puricelli L
    Oncol Rep; 2004 Nov; 12(5):1143-50. PubMed ID: 15492807
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Immunohistochemical localization of metallothionein in human breast cancer in comparison with cathepsin D, stromelysin-1, CD44, extracellular matrix components, P53, Rb, C-erbB-2, EGFR, steroid receptor content and proliferation.
    Ioachim E; Kamina S; Demou A; Kontostolis M; Lolis D; Agnantis NJ
    Anticancer Res; 1999; 19(3A):2133-9. PubMed ID: 10470161
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.